Background Palliative treatments and stents are necessary for relieving dysphagia in
patients with esophageal cancer. The aim of this study was to simultaneously compare …

Background Many patients with incurable esophageal cancer (ECa) present with dysphagia
as their predominant symptom. Currently there is no consensus on how best to initially …

Purpose: Between 1994 and 1997, 22 patients with dysphagia from advanced incurable
esophageal cancer were enrolled in a phase I/II prospective study to assess the palliative …

Background: The majority of patients with incurable esophageal adenocarcinoma suffer from
dysphagia. We assessed a novel treatment strategy with initial short-course radiotherapy …

Palliation of patients with obstructing or fistulizing esophageal cancer is not easy. Median
survival cannot be expected to be longer than 3–6 months, regardless of which therapy is …

The role of oesophageal stenting continues to evolve, with several new stents currently on
the market. These stents possess anti-reflux valves, internal plastic coatings and retrievable …

Between September 1987 and September 1993, 88 patients with oesophageal cancer were
treated by a single session of intraluminal brachytherapy of 15 Gy prescribed at 1 cm …

Background The objective of this study was to examine the impact of self-expanding stents
versus locoregional treatment modalities in the setting of esophageal cancer palliation …

Background Most patients with oesophageal and gastro‐oesophageal carcinoma are
diagnosed at an advanced stage and require palliative intervention. Although there are …

Introduction: Esophageal dysphagia is a commonly reported symptom with various benign
and malignant causes. Esophageal dysphagia can impede intake of oral medication, which …